Researchers can register and submit abstracts for the first joint meeting hosted by the Endocrine Society and Keystone Symposia—an intimate meeting designed to bring together researchers to advance understanding of how hormonal signaling shapes cancer risk, progression and treatment response.
Hormonal Influences on Immunity and Cancer Across the Lifespan, taking place in October in Breckenridge, Colo., will be the first of three joint meetings held by the organizations, which share a reputation for hosting top-flight scientific programming with luminary speakers. The conference series also will include two events on diabetes and cardiometabolic disease, which will both take place in February 2027 in Colorado. The events focus on understanding the foundations of chronic conditions that affect millions of people worldwide.
By combining the resources of two top scientific organizations, the Endocrine Society and Keystone Symposia are strengthening the exchange of scientific knowledge through coordinated programming. The conferences are designed to facilitate discovery and collaboration among basic and translational researchers, with the goal of catalyzing advances in foundational science. Ultimately, these discoveries can lead to breakthroughs that improve clinical outcomes for patients.
The event series includes:
•
Hormonal Influences on Immunity and Cancer Across the Lifespan (October 5-8, 2026 | Breckenridge, Colo.) brings together researchers across endocrinology, aging, and oncology to examine how hormonal signaling shapes disease in ways that are often overlooked when studied in isolation. Registration opens in late June.
•
Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies (February 1-4, 2027 | Keystone, Colo.) connects basic science, clinical research, and industry perspectives to better understand disease drivers and identify new therapeutic strategies.
•
Cardiometabolism and Interorgan Crosstalk: Novel Mechanisms and Therapies (February 16-19, 2027 | Breckenridge, Colo.) explores how communication across organ systems influences disease, highlighting emerging insights from genetics, immunology, and computational biology.
The conference format is designed to take scientific information from the bench to the bedside, and back to the bench—creating a continuum of learning and feedback that is vital for progress. The meetings will take place over 3.5 days, which maximizes opportunities for researchers to build relationships and network with their peers.
Amid a challenging research funding climate, the Society and Keystone will explore the importance of strategic partnerships in scientific discovery during a joint symposium at the Endocrine Society’s annual meeting,
ENDO 2026, on June 16 in Chicago, Ill. The joint panel,
“Keystone Symposia + Endocrine Society: How Partnerships Across the Life Sciences Benefit Researchers,” will feature researchers Ines Pineda Torra, Ph.D., David D'Alessio, M.D., Jennifer K. Richer, Ph.D., and Roger Cone, Ph.D. The session, co-moderated by Keystone Symposia's President and CEO Jamie Baumgartner, Ph.D., and Endocrine Society's Chief Learning Officer Christopher Urena, MBA, FASAE, CAE, will address how clinical observations shape research questions as well as mechanistic insights that guide new approaches to care—and how these ideas will come together in three upcoming meetings.
“These conferences provide a valuable opportunity for researchers across the endocrine spectrum to engage deeply, challenge assumptions, and inspire new directions in science,” said Endocrine Society President Carol Lange, Ph.D. “We are proud to partner with Keystone Symposia in the spirit of advancing science. By bringing discovery and translation together, we are strengthening the pipeline from innovation to patient care.”
Keystone Symposia is a nonprofit host of conferences and symposia on a range of life science and biomedical topics. Keystone Symposia specializes in holding intimate conferences in relaxed environments that encourage networking and foster connections among attendees.
“This partnership reflects something the scientific community needs now more than ever: environments where fundamental discovery, translational science, and clinical insight are not separated into silos, but intentionally brought together to accelerate progress,” Keystone’s Baumgartner said. “By combining the Endocrine Society’s global clinical leadership with Keystone Symposia’s strength in highly interactive, cross-disciplinary scientific meetings, we are creating a platform where researchers can challenge assumptions, form unexpected collaborations, and move ideas more rapidly from mechanistic discovery toward patient impact. At a time of increasing complexity in human disease and growing pressure on the research ecosystem, partnerships like this are essential to advancing science in ways no single organization can accomplish alone.”
About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers. The Endocrine Society is the largest global organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
With more than 18,000 members in 133 countries, the Society serves as the voice of the endocrine field. Through its renowned journals and ENDO, the world's largest endocrine meeting, the Society accelerates hormone research, advances clinical excellence in endocrinology, and advocates for evidence-based policies on behalf of the global endocrine community. To learn more, visit our online newsroom.
